{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:09:45Z","timestamp":1790651385424,"version":"4.1.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the clinical, immunological, and metabolomic factors associated with fibromyalgia (FM) in patients with idiopathic inflammatory myopathies (IIM) who are in clinical remission or complete response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional, 49 patients with IIM meeting remission and\/or complete clinical response criteria were evaluated with the PROMIS Pain Interference Short Form 8a as an initial screening tool and patients with clinically significant pain interference subsequently underwent assessment with the 2016 ACR criteria. Clinical data, flow cytometry of peripheral blood mononuclear cells, multiplex cytokine assays, and untargeted metabolomic profiling by GC-MS were performed. Multivariate logistic regression was used to identify variables associated with FM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of FM in this IIM cohort was 40.8%. FM was associated with higher patient global assessment scores, increased muscle damage, current prednisone use, and elevated serum levels of IL-6 and MCP-1. Immunophenotyping revealed reduced numbers of non-classical monocytes, CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, and B lymphocytes in FM patients. Metabolomic analysis identified lower concentrations of tryptophan and nonanoic acid in the FM group, suggesting altered pathways of immune regulation and nociplastic pain.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with IIM in remission and\/or complete clinical response can present with clinical significant FM, which is associated with immune dysregulation and metabolic alterations. These findings highlight the need for routine FM screening in IIM and support the use of patient-reported outcomes to distinguish between inflammatory and nociplastic symptoms in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1787182","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:43:40Z","timestamp":1777009420000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical, immunological and metabolomic risk factors associated with fibromyalgia in a cohort of patients with idiopathic inflammatory myopathies"],"prefix":"10.3389","volume":"17","author":[{"given":"Beatriz","family":"Alcal\u00e1-Carmona","sequence":"first","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Govea-Pel\u00e1ez","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiram","family":"Torres-Ruiz","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Alberto","family":"Carrillo-V\u00e1zquez","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer T.","family":"Balderas Miranda","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatzil","family":"Reyna-Ju\u00e1rez","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Ostos-Prado","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy R.","family":"Mej\u00eda-Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Red de Apoyo a la Investigaci\u00f3n, Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Ju\u00e1rez-Vega","sequence":"additional","affiliation":[{"name":"Red de Apoyo a la Investigaci\u00f3n, Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Paez-Franco","sequence":"additional","affiliation":[{"name":"Red de Apoyo a la Investigaci\u00f3n, Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilda","family":"S\u00e1nchez-Vidal","sequence":"additional","affiliation":[{"name":"Red de Apoyo a la Investigaci\u00f3n, Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Santana-De Anda","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Alejandre-Aguilar","sequence":"additional","affiliation":[{"name":"Laboratory of Entomology, Department of Parasitology, Escuela Nacional de Ciencias Biol\u00f3gicas, Instituto Polit\u00e9cnico Nacional","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Maravillas-Montero","sequence":"additional","affiliation":[{"name":"Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnolog\u00eda, Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Cuernavaca, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"G\u00f3mez-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n","place":["Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: a systematic review","volume":"54","author":"Meyer","year":"2015","journal-title":"Rheumatol (Oxford)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.26.11.1424","article-title":"Patient-reported dermatomyositis and polymyositis flare symptoms are associated with disability, productivity loss, and health care resource use","volume":"26","author":"Christopher-Stine","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20532","article-title":"Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)","author":"Rider","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180353","article-title":"Perceptions of patients, caregivers, and healthcare providers of idiopathic inflammatory myopathies: An international OMERACT study","volume":"46","author":"Mecoli","year":"2019","journal-title":"J Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002591","article-title":"Pain in autoimmune inflammatory myopathies: a scoping review","volume":"9","author":"Leclair","year":"2023","journal-title":"RMD Open"},{"key":"B6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s41927-020-00146-3","article-title":"Patient insights on living with idiopathic inflammatory myopathy and the limitations of disease activity measurement methods - a qualitative study","volume":"4","author":"Oldroyd","year":"2020","journal-title":"BMC Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-2972-8","article-title":"Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity","volume":"34","author":"Haliloglu","year":"2014","journal-title":"Rheumatol Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep458","article-title":"Fibromyalgic rheumatoid arthritis and disease assessment","volume":"49","author":"Pollard","year":"2010","journal-title":"Rheumatol (Oxford)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1590\/S0482-50042010000600005","article-title":"Occurrence of fibromyalgia in patients with ankylosing spondylitis","volume":"50","author":"Azevedo","year":"2010","journal-title":"Rev Bras Reumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080212","article-title":"Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity","volume":"36","author":"Wolfe","year":"2009","journal-title":"J Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab146","article-title":"Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis","volume":"60","author":"O'Mahony","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.874490","article-title":"Inflammation and interferon signatures in peripheral B-lymphocytes and sera of individuals with fibromyalgia","volume":"13","author":"Fineschi","year":"2022","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002089","article-title":"IL-5 mediates monocyte phenotype and pain outcomes in fibromyalgia","volume":"162","author":"Merriwether","year":"2021","journal-title":"Pain"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1993.35","article-title":"Amyopathic dermatomyositis: a review","volume":"100","author":"Euwer","year":"1993","journal-title":"J Invest Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/art.21291","article-title":"International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies","volume":"52","author":"Oddis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.04.025","article-title":"Development of a PROMIS item bank to measure pain interference","volume":"150","author":"Amtmann","year":"2010","journal-title":"Pain"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.06.006","article-title":"Assessing the content validity of patient-reported outcome measures in adult myositis: A report from the OMERACT myositis working group","volume":"50","author":"Esfandiary","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-022-00710-w","article-title":"Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data","volume":"17","author":"Pang","year":"2022","journal-title":"Nat Protoc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030658","article-title":"Myositis-specific and myositis-associated antibodies in fibromyalgia patients: a prospective study","volume":"11","author":"Sambataro","year":"2023","journal-title":"Biomedicines"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbre.2017.01.004","article-title":"Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia","volume":"57","author":"Chakr","year":"2017","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0806510","article-title":"The CD14+ CD16+ blood monocytes: their role in infection and inflammation","volume":"81","author":"Ziegler-Heitbrock","year":"2007","journal-title":"J Leukoc Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.08.012","article-title":"Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8","volume":"11","author":"Cros","year":"2010","journal-title":"Nat Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrrheum.2015.100","article-title":"Neuroinflammation in fibromyalgia","volume":"40","author":"Littlejohn","year":"2018","journal-title":"Semin Immunopathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1159\/000115041","article-title":"Lymphocyte subsets and the role of TH1\/TH2 balance in stressed chronic pain patients","volume":"14","author":"Kaufmann","year":"2007","journal-title":"Neuroimmunomodulation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/1471-2474-12-245","article-title":"Systematic review with meta-analysis: cytokines in fibromyalgia syndrome","volume":"12","author":"\u00dc\u00e7eyler","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030792","article-title":"Analysis of the influence of IL-6 and activation of the Jak\/Stat3 pathway in fibromyalgia","volume":"11","author":"Marino","year":"2023","journal-title":"Biomedicines"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2020.100067","article-title":"MCP-1 is increased in patients with CFS and FM, whilst several other immune markers are significantly lower than healthy controls","volume":"4","author":"Groven","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2024.1288024","article-title":"Pain and the biochemistry of fibromyalgia: patterns of peripheral cytokines and chemokines contribute to the differentiation between fibromyalgia and controls and are associated with pain, fat infiltration and content","volume":"5","author":"Gerdle","year":"2024","journal-title":"Front Pain Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.10.022","article-title":"Caprylic acid and nonanoic acid upregulate endogenous host defense peptides to enhance intestinal epithelial immunological barrier function via histone deacetylase inhibition","volume":"65","author":"Wang","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145088","article-title":"Short-chain fatty acids (except hexanoic acid) lower NF-\u03baB transactivation, which rescues inflammation-induced decreased apolipoprotein A-I transcription in HepG2 cells","volume":"21","author":"Tayyeb","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2025.1593908","article-title":"Redox reactions in chronic pain: mechanisms and relevance in fibromyalgia","volume":"6","author":"Ho","year":"2025","journal-title":"Front Pain Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"15925","DOI":"10.1038\/srep15925","article-title":"Systemic differences in serum metabolome: a cross sectional comparison of women with localised and widespread pain and controls","volume":"5","author":"Hadr\u00e9vi","year":"2015","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/0471142727.mb3004s114","article-title":"Metabolomics by gas chromatography-mass spectrometry: Combined targeted and untargeted profiling","volume":"114","author":"Fiehn","year":"2016","journal-title":"Curr Protoc Mol Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1787182\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:43:41Z","timestamp":1777009421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1787182\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2026.1787182"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1787182","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"1787182"}}